By Jaden Choi — a plain-English look at one of the most popular brain supplements and whether the trials back the marketing.

Ginkgo biloba has been sold as a memory pill for decades. Walk down any supplement aisle and you'll see it promising sharper focus, better recall, and protection against age-related decline. It's one of the best-selling herbal products in the world.

So here's the uncomfortable part: when researchers ran the biggest, longest, most careful trials to test exactly that promise, ginkgo didn't work. It didn't prevent dementia, and it didn't slow normal memory aging in healthy older adults. This piece walks through what those trials actually found, the one narrow situation where a small signal still survives, and why the ginkgo in the studies isn't quite the ginkgo on the shelf.

The short answer

If you're a healthy adult taking ginkgo to sharpen your memory or head off future decline, the best evidence says it doesn't do that. This isn't based on one small study — it's based on two landmark trials that together enrolled almost 6,000 older adults and followed them for years.

The nuance worth keeping: in people who already have a dementia diagnosis, a large 2026 review found ginkgo may offer a modest benefit for day-to-day function — but with low confidence, and that's a very different situation from a healthy person trying to stay sharp. So the honest answer isn't a flat "it's useless." It's "not for the reason most people buy it."

Where ginkgo's memory reputation came from

Ginkgo's reputation is older than the good evidence. The leaf extract has been used in traditional medicine for centuries, and in the 1990s and early 2000s a run of small trials suggested it might modestly help memory or mood. Lab work added a plausible story: ginkgo contains flavonoids and terpene compounds that act as antioxidants and can nudge blood flow, so the idea that it "feeds the brain" felt reasonable.

The problem is that early, small, and short trials are exactly the kind that tend to overstate a benefit — and marketing ran far ahead of the science. To really answer "does it prevent decline," you need a big trial that follows a lot of people for a long time. Those trials eventually got done, and the answer changed.

What the big prevention trials found

Two trials dominate this question because of their size and rigor. Both used EGb761, the standardized ginkgo extract used in most serious research, at 120 mg twice a day (240 mg total).

The GEM study (JAMA, 2008). The Ginkgo Evaluation of Memory trial, funded by the U.S. National Institutes of Health, randomized 3,069 adults aged 72 to 96 — some with normal cognition, some with mild cognitive impairment — to ginkgo or placebo and followed them for a median of about 6 years. The result: ginkgo did not reduce the rate of dementia or Alzheimer's disease. A 2009 analysis of the same group looked specifically at cognitive change — memory, attention, language, visual-spatial skills, executive function — and found no slowing of decline either.

The GuidAge study (Lancet Neurology, 2012). A French trial randomized 2,820 adults aged 70+ who had reported memory complaints to their doctor, giving them the same standardized ginkgo or placebo for 5 years. Again, ginkgo did not reduce progression to Alzheimer's disease: 61 cases in the ginkgo group versus 73 in the placebo group — a difference that wasn't statistically significant.

When two independent, well-run trials of this size point the same way, it's about as clear as prevention research gets: for keeping a healthy older brain from declining, standardized ginkgo didn't beat a placebo.

The one group where a signal survives

Prevention is one question. Treating people who already have cognitive problems is a separate one — and here the picture is a little less bleak.

A 2026 Cochrane review — the gold standard of evidence summaries — pooled 82 randomized trials with 10,613 participants and sorted the results by who was being treated. The findings split cleanly by group:

• People worried about their memory (but no diagnosis): it's uncertain whether ginkgo beats placebo at around 6 months.
• People with mild cognitive impairment (MCI): ginkgo is probably not better than placebo for overall condition, thinking, or everyday tasks.
• People already diagnosed with dementia: ginkgo may be better than placebo for overall condition, thinking, and daily-living skills at 6 months.

That last line is the strongest thing you can honestly say for ginkgo — but read it carefully. The review rates that dementia-group benefit as low certainty, meaning future trials could easily change it, and many of the studies were small or older. It's a "maybe, modestly, in people who are already sick," not a memory upgrade for a healthy brain.

What about healthy adults who just want sharper focus?

This is the biggest market for ginkgo — students, busy professionals, people in their 40s and 50s noticing the occasional "why did I walk into this room" moment. And it's the group with the least support.

The large trials above were in older adults, but they're the most relevant data we have on whether ginkgo protects cognition over time, and they came up empty. Smaller studies in healthy younger and middle-aged adults have been inconsistent and generally unimpressive — no reliable, repeatable boost to memory, attention, or "brain fog." There's no good evidence that ginkgo makes a healthy, well-functioning brain work better.

If day-to-day forgetfulness is bothering you, the boring interventions have far stronger evidence behind them than any supplement: consistent sleep, regular exercise, managing blood pressure and blood sugar, and staying socially and mentally active. Those aren't as easy to bottle, which is partly why the supplement wins on marketing even when it loses on data.

The extract in the study isn't the one on the shelf

Here's a detail that gets lost: nearly all the credible ginkgo research used EGb761, a specific, standardized extract made to a fixed recipe — roughly 24% flavone glycosides and 6% terpene lactones, with the naturally occurring ginkgolic acids reduced because they can be irritating.

A random bottle of "ginkgo biloba" from a discount shelf may or may not match that. Herbal supplements aren't reviewed for effectiveness before sale, and independent testing has repeatedly found products whose actual content doesn't match the label — sometimes with little of the active compounds, sometimes cut with cheaper fillers. So even the modest, uncertain dementia-group signal was tied to a specific, quality-controlled extract, not to whatever happens to be in a given capsule.

Is ginkgo at least safe?

For most healthy adults, standardized ginkgo taken by mouth appears to be reasonably well tolerated in trials, with side effects like headache, stomach upset, or dizziness. But "generally tolerated" isn't the same as "harmless for everyone," and a few cautions are worth knowing.

What the research still can't tell us

Being honest about the gaps is what separates a summary from a sales pitch.

• The dementia-group signal is fragile. "May help" at low certainty means it could shrink or disappear as better trials arrive — it's a lead, not a conclusion.
• Older trials were uneven. Many early studies were small, short, or used different products and doses, which is exactly why the big, standardized prevention trials carry more weight.
• Real-world products vary. Since content isn't guaranteed, even a person who wanted to replicate the studied dose can't be sure their capsule matches it.

The fair verdict: for a healthy adult chasing a memory boost or trying to prevent decline, ginkgo has been tested at scale and came up short. The only place a small, uncertain benefit lingers is people already living with dementia — a decision for them and their doctor, not a reason to stock up preventively.

Frequently Asked Questions

Bottom Line

Ginkgo biloba is a case where the marketing outran the evidence and never caught back up. Tested in two large, careful trials, it didn't prevent dementia or slow normal memory aging. The single honest bright spot — a possible, low-certainty benefit for people who already have dementia — is not the reason most people buy it.

If you're worried about your memory, that's worth a real conversation with your doctor, not a supplement bought on reputation. And the habits with the strongest evidence for a healthy brain — sleep, movement, and controlling blood pressure and blood sugar — are still the ones no capsule has beaten.

---

Sources

• DeKosky ST, Williamson JD, Fitzpatrick AL, et al. "Ginkgo biloba for prevention of dementia: a randomized controlled trial" (GEM Study). JAMA, 2008;300(19):2253–2262. PubMed
• Snitz BE, O'Meara ES, Carlson MC, et al. "Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial." JAMA, 2009;302(24):2663–2670. PubMed
• Vellas B, Coley N, Ousset PJ, et al. "Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial." Lancet Neurology, 2012;11(10):851–859. PubMed
• Wieland LS, et al. "Ginkgo biloba for cognitive impairment and dementia." Cochrane Database of Systematic Reviews, 2026, Art. No.: CD013661.pub2 (82 trials, 10,613 participants). Cochrane Library
• National Center for Complementary and Integrative Health (NIH). "Ginkgo." nccih.nih.gov

This article summarizes published research for general educational purposes and is not medical advice. It does not diagnose, treat, or recommend any specific treatment, dose, or supplement. If you have concerns about your memory or are considering any supplement — especially alongside other medications — talk to your doctor or a licensed healthcare provider. Research evolves and findings can be revised. Information is current as of August 2026.